Literature DB >> 28854318

Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors.

Daniel M Blumenthal1,2, Dana Goldman3,4, Anupam B Jena5,6,7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28854318     DOI: 10.1001/jamacardio.2017.2959

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  1 in total

1.  The economics of alternative payment models for pharmaceuticals.

Authors:  Jakub P Hlávka; Jeffrey C Yu; Dana P Goldman; Darius N Lakdawalla
Journal:  Eur J Health Econ       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.